Abstract
16
Membrane transporters and channels are generally assumed to be based on distinct structural 17
and functional principles. SLC26A11, a solute carrier with high expression levels in the brain, 18
has been proposed to function as either an anion transporter or a channel. Here, we resolve 19
this apparent discrepancy by demonstrating that SLC26A11 is a dual-function protein capable 20
of operating as both a sulfate transporter and a chloride channel. By resolving its structure 21
and combining biochemical studies and molecular dynamics simulations, we show that 22
SLC26A11 exhibits all the hallmarks of a secondary transporter. The mechanistic basis for its 23
selective ion transport identifies the protein as the elusive lysosomal sulfate exporter. 24
Additionally, we demonstrate that S LC26A11 exhibits an uncoupled, channel -like chloride 25
conductance gated by proton:sulfate symport. Our finding that the chloride-conducting state 26
arises from the transport cycle may contribute to the development of novel therapeutic 27
strategies for treating brain edema, and the identification of its role in lysosome sulfate efflux 28
may provide new approaches to study and treat lysosomal storage diseases. 29
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
3
Main text 30
Introduction
31
SLC26A11, or KBAT for kidney and brain anion transporter, is expressed in most tissues, with 32
the highest expression levels in the brain 1,2. SLC26A11 is a member of the solute carrier 33
family 26 (SLC26) of secondary transporters of small anions 3,4. Initially, SLC26A11 was 34
described as a pH-dependent transporter of sulfate, chloride, and oxalate 1,5,6, consistent with 35
its close phylogenetic relationship to plant and yeast sulfate transporters 6. However, 36
subsequent electrophysiological studies in HEK293 cells 7 and neurons 8,9 have suggested 37
that SLC26A11 functions as a chloride channel. This putative chloride channel activit y of 38
SLC26A11 has been implicated in pathological neuronal swelling 8 and its inhibition has been 39
proposed as a therapeutic strategy for ischemic stroke 9. 40
Membrane transporters and channels are generally assumed to be based on different 41
functional and structural principles 10,11. Based on their structure, SLC26 proteins are assumed 42
to function as transporters that operate according to an elevator-type transport mechanism 12. 43
Detailed functional studies have supported this claim by demonstrating that several SLC26 44
family members are secondary transporters that catalyze either anion symport 13,14 or 45
exchange 15. However, electrophysiological measurements have also demonstrated channel-46
like uncoupled chloride transport for other SLC26 proteins, i.e., SLC26A7 16-19, and SLC26A9 47
20-23. Thus far, it has not been possible to determine whether these uncoupled chloride fluxes 48
are caused by a chloride-selective channel or a fast chloride uniport transport-mode 24. 49
Until now, the function of SLC26A11 has only been studied in the plasma membrane. 50
However, proteomic 25,26 and transcriptomic 27-29 studies and confocal microscopy 30 have 51
identified SLC26A11 as a lysosomal membrane protein. Lysosomes are the primary 52
degradative compartments of the cell 31. Lysosomal recycling of macromolecules depends on 53
the concerted action of lysosomal hydrolases and transporters for catabolite export to the 54
cytosol 32-35. Functional defects in either lead to the accumulation of degradation products and 55
Result
in lysosomal storage diseases (LSDs) 36,37. While lysosomal sulfatases and their 56
causative role in LSDs are well characterized 38, little is known about the efflux of the resulting 57
sulfate 39, a process critical for preventing competitive inhibition of sulfatases 40,41. Although 58
the existence of a lysosomal sulfate clearance pathway has been described 42, its molecular 59
identity has remained unknown. 60
Here we characterize the three-dimensional structure and function of human SLC26A11. Our 61
structures of nanobody -bound SLC26A11 reveal the most compact structure of any 62
mammalian SLC26 transporter. SLC26A11 further exhibits all the hallmarks of a secondary 63
transporter. By combining biochemical studies and molecular dynamics simulations, we show 64
that SLC26A11 is tailored to function as the elusive lysosomal sulfate exporter and provide 65
the mechanistic basis for its highly selective ion transport. We further demonstrate that 66
SLC26A11 is also capable of an uncoupled, channel-like chloride conductance, which is gated 67
by proton and sulfate transport. Taken together, our work identifies SLC26A11 as a protein 68
with a dual transport-channel function. The identification of its role in lysosome sulfate efflux 69
may pave the way to new approaches to study and treat lysosomal storage diseases. Our 70
finding that the chloride-conducting state emerges from a conformation part of the secondary 71
transport cycle may open a path to a therapeutic strategy for the treatment of brain edema. 72
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
4
Results
73
SLC26A11 is a proton:sulfate/chloride exchanger 74
Thus far, functional characterization of SLC26A11 has been performed in cell -based assays 75
1,6,7,43. These assays exclusively study proteins inserted into the plasma membrane and permit 76
only limited control of ion gradients . Therefore, we performed a detailed in vitro 77
characterization of purified and membrane-reconstituted human SLC26A11 ΔC, a variant 78
lacking the C-terminal intrinsically disordered region of 23 amino acids [ Supplementary Fig. 79
1A-C]. Consistent with a similar truncation mutant of murine SLC26a9 24, SLC26A11 ΔC 80
showed higher expression levels than full -length SLC26A11 and excellent biochemical 81
behavior [Supplementary Fig. 1D-G]. 82
Since the related Arabidopsis transporter, AtSultr4;1, performs pH-dependent sulfate transport 83
14, we first studied SLC26A11ΔC under similar conditions (pHout 5.0; pHin 7.5). We observed a 84
time-dependent accumulation of 35S-sulfate in SLC26A11 ΔC proteoliposomes, in contrast to 85
liposomes without protein [Fig. 1A ]. We observed that sulfate accumulation was strongly 86
dependent on the presence of chloride ions in trans. Substitution of internal gluconate for 87
chloride increased the initial rate of sulfate transport and the final accumulation level 88
approximately fourfold. Therefore, we included 50 mM chloride in the lumen of the 89
proteoliposomes in subsequent measurements. 90
We further measured SLC26A11ΔC sulfate transport at different pH gradients. Sulfate uptake 91
showed a strong pH dependence, and the highest degree of sulfate accumulation was 92
observed for pH gradients of 2.0-2.5 units and with the acidic pH outside [Fig. 1B ]. Lower 93
levels of sulfate accumulation were observed in the presence of a symmetrical pH of 7.5 or 94
5.0. Since no change in sulfate accumulation was observed in the presence or absence of an 95
inward Na+-gradient, sulfate uptake does not appear to involve Na+ ions, in agreement with a 96
previous study 6 [Supplementary Fig. 2A]. These results suggest that sulfate transport is 97
obligatorily coupled to proton transport in the same direction. We determined an apparent K M 98
of 39.7 ± 5.5 µM for sulfate in the presence of a strong pH gradient (pHout 5.0; pHin 7.5) [Fig. 99
1C]. 100
Next, we systematically varied the chloride concentrations in both compartments to explain 101
the stimulatory effect of trans chloride on sulfate transport [ Fig. 1D]. While the presence of 102
chloride in the trans compartment led to strong sulfate accumulation, the presence of chloride 103
in both compartments showed similar reduced uptake levels as observed in the absence of 104
chloride. Sulfate uptake was further reduced in the presence of chloride in the cis compartment 105
only. Together, this indicates that chloride is not an allosteric modulator of SLC26A11, but 106
rather acts as a substrate competing with sulfate for the same binding site when present in 107
the cis compartment, and functions as a counter -substrate when present in the trans 108
compartment. 109
To determine whether SLC26A11 is an obligate exchanger, we first identified anions capable 110
of inhibiting 35S-sulfate uptake. We observed strong inhibition upon addition of a 100-fold 111
excess of thiosulfate, oxalate and selenate to the cis compartment [Fig. 1E ]. Molybdate, 112
iodide, acetate and chloride inhibited transport to a lesser extent, whereas phosphate and 113
bicarbonate had no effect on SLC26A11ΔC activity. Next, we loaded proteoliposomes with 35S-114
sulfate until steady state was reached before dissipating the proton gradient. In the absence 115
of external substrate, the proteoliposomes retained ~90% of the sulfate over the next 32 116
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
5
minutes [Fig. 1F]. However, upon addition of a 100-fold excess of unlabeled sulfate, oxalate, 117
or selenate, we did observe efflux of most of the 35S-sulfate from the proteoliposomes. The 118
limited degree of 35S-sulfate efflux in the absence of a counter -substrate suggests that the 119
energetic barrier for a conformational transition in the absence of substrate is very high. Thus, 120
SLC26A11 appears to function most efficiently as an exchanger. 121
Figure 1: Sulfate transport of SLC26A11 is pH and chloride dependent. (A) Time dependent
sulfate uptake into SLC26A11 proteoliposomes in presence of a pH gradient (pH 7.5 inside, pH 5.0
outside) and 50 mM internal chloride (blue) or 50 mM gluconate as chloride substitute (dark grey)
and empty liposome control (light grey). (B) pH dependence of sulfate transport in presence of 50
mM internal chloride and with internal and external pH as indicated below the individual bars. A Two-
tailed Student’s t test was performed (*** indicates p < 0.001, p values are shown in the Source Data
file). (C) Sulfate transport kinetics. Data represents background-corrected initial sulfate uptake after
20 seconds in presence of increasing sulfate concentrations. K m and Vmax were derived from non-
linear curve fitting using the Michaelis -Menten function in OriginPro. (D) Chloride dependence of
sulfate transport with internal and external 50 mM chloride or 50 mM gluconate as chloride substitute
as indicated below the individual bars. (E) Inhibition of sulfate transport in presence of different anions
as indicated below individual bars. Anions were added as sodium salt at 100- fold the concentration
of external sulfate. A Two-tailed Student’s t test was performed (*** p < 0.001, ** p < 0.01, * p < 0.05,
p values are shown in the Source Data file). (F) Sulfate efflux from proteoliposomes upon sulfate
uptake as shown in panel A. Sulfate efflux was initiated by addition of 100 nM CCCP and different
anions at 100- fold external sulfate concentration as indicated. For all experiments in Fig. 1, the
individual datapoints as well as the mean ± SEM (n ≥ 3) are shown. Assay buffers and precise number
of replicates are detailed in Supplementary Table 1. Bar graphs represent background- corrected
sulfate accumulation levels reached after 16 min of transport.
Combined these results suggest that SLC26A11 can transport protons and sulfate ions in one 122
direction and chloride ions in the opposite direction. To approximate the stoichiometry of 123
transported ions, we measured (cis) proton- and (trans) chloride-driven sulfate accumulation 124
in the presence of different membrane potentials [Supplementary Fig. 2B]. We observed 125
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
6
only modest changes when generating a membrane potential of 0 and +60 mV, but at -60 mV 126
sulfate accumulation was reduced by approximately 30%. For electrogenic transport, a more 127
pronounced reduction at -60 mV and a concomitant increase in sulfate accumulation at +60 128
mV would be expected, as shown for the proton:fumarate symporter SLC26Dg 13. These 129
Results
therefore support an electroneutral transport mode for SLC26A11. In the most 130
parsimonious model, SLC26A11 is an exchanger that couples the symport of one proton and 131
one sulfate ion (net charge of -1) to the antiport of one chloride ion (net charge of -1). 132
Figure. 2: Structures of human SLC26A11 ΔC reveal three unique features. (A) Cryo-EM
reconstruction of the dimeric SLC26A11 ΔC-Nb11 (blue) and SLC26A11ΔC-Nb4 (green) complexes
embedded in an MSP1-E3D1 nanodisc. Nanobody densities are shown in grey and the MSP1-E3D1
density, indicative of the position of the lipid bilayer, is shown as transparent belt. (B) View on the
extracellular side of SLC26A11 ΔC showing the transport (green) and scaffold domains (light green)
connected by two interdomain linkers and the intracellular STAS domain. (C) Alternative N -
glycosylation site in SLC26A11 in the β -hairpin loop TM7-8. The electron density corresponding to
the NAG group attached to Asn -294 is shown as blue mesh. Inset: PNGase F treatment increases
the electrophoretic mobility of SLC26A11 ΔC. (D) Helix kinking of TM7 at Ala -246 results in an
extended conformation of loop TM6-7 containing the PxxPxxP SH3 binding motif. The position of the
lipid bilayer, derived from the nanodisc density, is indicated as grey lines.
Overall structure of human SLC26A11 133
We determined structures of SLC26A11 ΔC in MSP1 -E3D1 nanodiscs supplemented with 134
phosphatidylcholine to gain insight into the mechanistic basis of sulfate transport coupled to 135
the cis proton- and trans chloride-gradients. As fiducial markers for cryo-electron microscopy, 136
we selected two nanobodies, Nb4 and Nb11, from alpaca immune libraries based on their 137
opposite effects on the transporter’s thermal stability [Supplementary Fig. 3], resulting in two 138
highly similar structures (RMSD of 0.56 Å) with an overall resolution of 2.8 Å (Nb4) and 3.2 Å 139
(Nb11) [Fig. 2A, Supplementary Fig. 4-7]. Nb4 and Nb11 each bind SLC26A11ΔC on the side 140
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
7
of the membrane domain that faces the lysosomal lumen or the extracellular environment, but 141
they bind in different locations. 142
Both structures of nanobody -bound SLC26A11 ΔC show an SLC26A11 homodimer with 143
cytoplasmic STAS domains swapped between the protomers and two nanobodies binding the 144
membrane domain on the extracellular side. The SLC26A11 membrane domain is composed 145
of 14 transmembrane segments (TMs) arranged in two inverted repeats of seven TMs, a fold 146
shared by the SLC4, SLC23 and SLC26 families 44. The membrane domain can be further 147
subdivided into a compact transport domain flanked on one side by an elongated scaffold 148
domain [Fig. 2B]. On either side of the membrane, these subdomains are connected by α -149
helical interdomain-linkers that coordinate the relative reorientation of the transport domain 150
that underlies solute transport 45. The structure of SLC26A11, while conforming to the overall 151
design 12,15,24,46-52, deviates markedly from other mammalian SLC26 proteins in each of the 152
three subdomains [Supplementary Fig. 8]. 153
In the transport domain, all other human isoforms carry one or more glycosylation sites in the 154
elongated, extracellular loop bridging TM3-4. This loop is kept compact in SLC26A11 155
[Supplementary Fig. 8A ]. The SLC26A11 ΔC-Nb11 structure instead shows a β-hairpin 156
extension in loop TM7-8, immediately adjacent to TM3-4. This hairpin is in close contact with 157
Nb11. At its tip, this loop carries an additional density at the known glycosylation site Asn-294 158
53, where we modeled an N -acetylglucosamine (NAG) moiety [Fig. 2C]. We confirmed the 159
presence of N-glycosylation in our SLC26A11 sample by PNGase F treatment [Fig. 2C]. The 160
TM7-8 loop is not resolved in the SLC26A11ΔC-Nb4 structure. Given that Nb4 does not interact 161
with the hairpin, this suggests that it is highly mobile in the absence of a binding partner. 162
The second structural deviation in SLC26A11 involves TM7 in the scaffold domain [Fig. 2D ]. 163
Compared to other human SLC26 proteins, TM7 is comparably long and is kinked within the 164
membrane so that the intracellular half is at an angle of 107° to the extracellular half 165
[Supplementary Fig. 8A ]. The break in the helix occurs at Ala-246 and appears to be 166
stabilized by positioning the intracellular amphipathic half of TM7 at the membrane inter face 167
in the lipid bilayer . As a consequence of this arrangement, the intracellular loop TM6-7 is 168
extended, presenting a potential protein-protein interaction motif, a class VIII SH3 domain 169
binding sequence 54. 170
Finally, SLC26A11 contains the most compact STAS domain of all human SLC26 transporters 171
[Supplementary Fig. 8A ]. This is due to the absence of an internal intrinsically disordered 172
sequence, the so-called intervening sequence, and a comparatively short disordered C -173
terminus [ Supplementary Fig. 1]. In contrast to other human SLC26 proteins, the interface 174
between adjacent STAS domains is very small [Supplementary Fig. 9]. Instead, the dimer 175
interface is largely composed of interactions between the STAS domains and TM5, TM12, 176
TM13, and the intracellular interdomain linker, which are all part of the scaffold domain. 177
Molecular basis for proton coupling 178
The substrate binding site is located in the center of the transport domain and faces the 179
scaffold domain. It consists of a small cavity lined by TM1 and TM8 and the short α-helical 180
sections of TM3 and TM10 [Fig. 3A, B ]. Both structures capture SLC26A11 ΔC in the same 181
conformation with the substrate binding site accessible from the cytoplasm via a water -filled 182
cavity, suggesting an inward-open conformation [Fig. 3A]. We observed an additional density 183
in the substrate binding site, which we modelled as a putative buffer-derived chloride ion [Fig. 184
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
8
3B]. While the substrate binding site itself is stabilized by a network of hydrogen bonds, we 185
did not observe any specific interactions between the chloride ion and the residues lining the 186
substrate binding site. Averaged ion densities from extensive all -atom MD simulations (vide 187
infra) revealed that chloride and sulfate can bind at this site, allowing for the unambiguous 188
assignment of the observed density [Supplementary Fig. 10, 11]. Chloride binding thus 189
appears to be based on electrostatic interactions involving the positive dipoles of the α-helical 190
segments of TM3 and TM10 and the side chain of Arg-366 [Fig. 3B]. 191
To identify the molecular basis for proton-coupling, we performed all-atom molecular dynamics 192
(MD) simulations of SLC26A11 with standard aqueous protonation states at pH 7 193
[Supplementary Fig. 10, 11]. For each titratable residue, we determined its average pK a 194
value over the course of the entire set of initial simulations (6.52 µs) and compared it to the 195
corresponding standard pKa value in an aqueous environment [Fig. 3C]. While the pKa values 196
of all histidine residues fall within the physiologically relevant pH range, these residues are 197
located at the periphery of the protein [Supplementary Fig. 12]. Due to the comparatively 198
large basic shift of its pKa, Glu-320 also falls within the relevant pH range. Glu-320 is situated 199
Figure 3: Milieu of the SLC26A11 binding site depends on a titratable residue. (A) Surface
representation of SLC26A11ΔC-Nb4 clipped through the substrate binding site, indicated by a green
asterisk, showing the inward -facing cavity. (B) Substrate binding site of SLC26A11 with bound
chloride ion (green sphere), water molecules (red spheres) and corresponding electron densit ies
shown as blue mesh. Hydrogen bonds are shown as black dotted lines. (C) Experimental aqueous
pKa values compared to simulated pK a values of aqueous -exposed and buried titratable residues.
The grey rectangle denotes the physiologically relevant pH range for proton-coupled transport. (D)
Multiple sequence alignment among the human SLC26 family members, depicting a segment of TM8.
The position of Glu-320 in SLC26A11 is indicated by the grey box. (E-F) Substrate binding site full
system electrostatics in a sphere of 7-Å radius surrounding the binding site’s center-of-geometry. The
substrate binding site of SLC26A11 is shown with Glu-320 in the deprotonated (E) and protonated
state (F). Glu-320 is shown in stick representation.
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
9
in TM8 and directly flanks the substrate binding site [Fig. 3B ]. This analysis highlights Glu-200
320 as the most suitable residue for proton-coupling. 201
Sequence alignment of the ten human family members shows that Glu-320 is unique to 202
SLC26A11 [Fig. 3D]. Although Glu-320 lines the substrate binding site, its carboxylate group 203
appears to be too distant to contribute directly to ion coordination [Fig. 3B]. However, the 204
protonation state of Glu-320 strongly affects the mean electrostatic potential in and around the 205
substrate binding site [ Fig. 3E, Fig. 3F], consistent with a potential long-range electrostatic 206
contribution to substrate binding. 207
208
Figure 4: Sulfate binding to SLC26A11 is selectively controlled by the protonation state of
Glu-320. (A) Thermal unfolding of SLC26A11ΔC at pH 5.0 (top) and pH 7.5 (bottom) in the presence
of increasing sulfate concentrations (blue = 0 mM sulfate, red = 80 mM sulfate). Shown are mean
and standard deviation (n = 3 ) of the first derivative of F 350/F330. The melting temperature T m is
reported by the local minimum of d(F350/F330)/dT. (B) pH-dependence of the substrate binding affinity
(KD) of SLC26A11ΔC and standard deviation derived from non-linear curve fitting using OriginPro of
Tm/Tm-apo derived from panel A and [Supplementary Fig. 13]. (C) Binding affinity (KD) and binding
rates (kon, koff), for sulfate and chloride, derived from all -atom equilibrium molecular dynamics
simulations under different protonation states of Glu -320. E320p denotes the protonated species.
Distributions of values come from six independent dimer simulations for each condition, with each
subunit considered independent, resulting in 12 independent replicates per calculation. (D) Thermal
unfolding of SLC26A11ΔC(E320Q) as in panel A. (E) pH-dependence of the KD and standard deviation
of SLC26A11ΔC( E320Q) as shown in panel B. (F) Sulfate transport of SLC26A11 ΔC as shown in
Figure 1B and SLC26A11 ΔC( E320Q) in presence or absence of a proton gradient as indicated.
Shown are background corrected mean, SEM and individual data points (n = 3) after 16 minutes of
transport. A Two-tailed Student’s t test was performed.
209
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
10
Glu-320 protonation controls substrate binding 210
The presence of a titratable residue in the substrate binding site prompted us to determine the 211
relationship between substrate binding and pH. We first measured the binding of chloride and 212
sulfate at pH 5.0 and pH 7.5 using differential scanning fluorimetry (DSF ) and derived 213
dissociation constants [Fig. 4A, B, Supplementary Fig. 13]. Chloride binding to SLC26A11ΔC 214
was independent of pH with apparent KD values of 6.0 ± 1.4 and 5.3 ± 0.7 mM at pH 5.0 and 215
pH 7.5, respectively. For sulfate we observed strong binding at pH 5.0 with an apparent KD of 216
57 ± 11 µM. However, at pH 7.5, sulfate binding was less favorable with an apparent KD of 2.9 217
± 0.4 mM. Thus, while chloride binding remained constant, the affinity for sulfate changed by 218
almost two orders of magnitude as a function of pH. 219
Next, we used DSF to analyze the pH-dependent binding of other mono- and divalent anions 220
that act as SLC26A11 substrates [Fig. 1E, F]. As with chloride, we did not observe a strong 221
pH-dependent change in binding affinity for iodide and acetate, which are completely and 222
predominantly mono-anionic, respectively, under these conditions [Supplementary Fig. 14]. 223
In contrast, the divalent anions oxalate, thiosulfate, selenate and molybdate showed a strong 224
decrease in binding affinity, upon shifting from pH 5.0 to pH 7.5, similar to that observed for 225
sulfate. Taken together, this suggests that the charge of the anion is the major determinant of 226
pH modulation of binding affinity. 227
Given the impact of the protonation state of Glu-320 on the surface potential of the substrate 228
binding site [Fig. 3E, F], we determined the sulfate and chloride binding constants for 229
protonated and deprotonated Glu-320 using equilibrium MD simulations. Over a timespan of 230
~15 µs, we captured hundreds of spontaneous binding and unbinding events, which we used 231
to evaluate the kinetic binding constants [Fig. 4C]. Protonation of Glu-320, which occurs under 232
acidic conditions, results in a slight increase in in silico association rates (kON) for chloride and 233
sulfate, and a slight decrease in the dissociation rates (k OFF) of both ions. However, both 234
changes are more pronounced for sulfate, resulting in a significant change in binding affinity 235
only for this ion. The dissociation constant for sulfate is reduced by almost an order of 236
magnitude upon protonation of Glu-320. These results are in good quantitative agreement with 237
the biochemical experiments, which also show an increased affinity for sulfate, but not for 238
chloride, upon protonation, and demonstrate that the protonation state of Glu-320 controls the 239
substrate-specific binding affinity. 240
As a mimic of the protonated state, we introduced the E320Q mutant, designated 241
SLC26A11ΔC(E320Q). The chloride dissociation constant of SLC26A11 ΔC(E320Q), as 242
determined by DSF, was comparable to that of the wild type protein at pH 5.0 (8.8 ± 1.4 mM) 243
and was increased six-fold at pH 7.5 (30 ± 4.0 mM) [Fig. 4D, E]. However, the most significant 244
c
hange was observed for sulfate. While the binding affinity remained high at pH 5.0 (KD 19 ± 245
4.0 µM ), the E320Q mutant showed a similarly high affinity at pH 7.5 (K D 13 ± 3.0 µM ), 246
representing a more than 200-fold increase in binding affinity compared to the wild type 247
protein. This further supports a critical role of the Glu-320 protonation state in the sulfate but 248
not the chloride binding affinity, with the protonated and deprotonated species allowing sulfate 249
binding with micromolar and millimolar affinities, respectively. The agreement between the KD 250
for sulfate at pH 5.0 [Fig. 4B] and the apparent KM for sulfate transport [Fig. 1C] is consistent 251
with sulfate being transported with a proton. 252
Finally, we did not observe any (cis) proton- and (trans) chloride-driven sulfate accumulation 253
in SLC26A11ΔC(E320Q) proteoliposomes [Fig. 4F]. This is consistent with the very high, pH -254
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
11
independent sulfate binding affinity of the mutant and the slight decrease in chloride binding 255
affinity at high pH, which together are expected to result in a very low efficiency of sulfate-for-256
chloride exchange in the liposomal lumen. 257
258
259
260
Figure 5: SLC26A11 exhibits pH- and sulfate-dependent intrinsic chloride channel activity. (A)
Representative current recordings from Sf9 cells expressing SLC26A11(WT) -eGFP with buffer
conditions as shown in panel B. (B) Current-voltage relationships (means ± standard errors; n =
13/11/7) from transfected Sf9 cells in three different bath solutions as indicated (grey: 0 mM sulfate,
pH 7; blue: 10 mM sulfate, pH 7; red: 10 mM sulfate, pH 6.0). (C) Current-voltage relationships
(means ± standard errors; n = 9/10) from untransfected Sf9 cells in the same solutions as indicated
in panel B. (D, E) Representative whole- cell current traces (D) and current -voltage relationships
(mean ± standard errors; WT: n = 29/6, E320Q: n = 25/11) (E)
for SLC26A11(WT) and
SLC26A11(E320Q) in absence or presence of a pH gradient (blue: symmetrical pH 7.33; red: pH out
6.00, pHin 7.33). (F) upper panel: Reversal potentials (Urev) for SLC26A11(WT) at different external
pH values presented as whisker -box plots. Boxes indicate upper and lower 75/25% quartiles with
medians. Whiskers span 95% confidence limits. Data points are derived from experiments shown in
panel D and E and Supplementary Fig. 19. lower panel: Current amplitudes of SLC26A11(WT) and
SLC26A11(E320Q) at -120 mV at experimental conditions as shown in panel E at various external
pH conditions (pH 7.33/7.00/6.66/6.33/6.00; WT: n =29/20/12/7/6, E320Q: n = 25/15/12/12/11).
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
12
SLC26A11 is a chloride channel 261
Since previous electrophysiological studies have suggested that SLC26A11 can function as 262
an anion channel 7-9, we next studied the electrophysiological properties of SLC26A11 via 263
whole-cell patch clamp. For these experiments we used Spodoptera frugiperda (Sf9) insect 264
cells: whereas SLC26A11 exclusively localizes to lysosomes in various mammalian cell lines 265
30, a fraction of the SLC26A11 protein localizes to the plasma membrane in Sf9 cells 266
[Supplementary Fig. 15]. 267
At neutral pH and in the absence of sulfate, we did not observe any SLC26A11- mediated 268
current above background [Supplementary Fig. 16]. However, in the presence of 0.5 mM 269
sulfate in the internal solution, we detected small SLC26A11 currents (-114 ± 18 pA at -120 270
mV) at symmetrical chloride concentrations [Fig. 5A -B]. These currents exceeded the 271
Background
currents in non-transduced cells (-56 ± 14 pA at -120 mV) [Fig. 5C], suggesting 272
that the observed current is conducted by SLC26A11. 273
SLC26A11-specific current amplitudes further increased in the presence of 10 mM external 274
sulfate (-463 ± 140 pA at -120 mV) and upon subsequent acidification of the bath solution from 275
pH 7.0 to 6.0 (-833 ± 374 pA at -120 mV) [Fig. 5A-C]. While the latter conditions are in principle 276
compatible with sulfate binding and transport into cells, currents of similar magnitude were 277
also detected under conditions with opposite ion distributions compatible with sulfate binding 278
on the cytoplasmic side and subsequent export [Supplementary Fig. 17]. Under conditions 279
with high internal sulfate concentrations, currents further increased with a stronger outward 280
pH gradient (pHin 6.0; pHout 8.5). Thus, conditions that favor proton:sulfate transport enhance 281
SLC26A11 currents. Under all conditions the current reversal potential remained close to the 282
Nernst equilibrium potential for chloride, indicating that the observed current is chloride-283
selective. This is further supported by the altered reversal potential observed upon depletion 284
or substitution of external chloride [Supplementary Fig. 18]. 285
Given the impact of Glu-320 protonation on substrate selectivity and transport, we examined 286
the consequences of the E320Q mutation on SLC26A11-specific whole-cell currents. 287
SLC26A11(E320Q) showed similar expression levels and intracellular distribution as the wild 288
type protein [Supplementary Fig. 15]. However, whereas SLC26A11(WT )-specific currents 289
w
ere activated by external acidification at high external sulfate, SLC26A11(E320Q ) anion 290
currents instead remained low but exceeded background currents [Fig. 5D-F, Supplementary 291
Fig. 19]. The lack of pH -dependence observed for SLC26A11(E320Q ) chloride currents 292
suggests that activation of the chloride channel requires the protein to cycle through different 293
Glu-320 protonation states, as previously observed for the electroneutral 294
proton:sulfate/chloride exchange mode of transport [Fig. 4F]. 295
Taken together, our findings indicate that SLC26A11 exhibits two distinct transport functions: 296
electroneutral proton:sulfate/chloride exchange and chloride channel activity. In conjunction 297
with the sulfate dependency of chloride channel activation, the distinct pH dependence of the 298
currents recorded with internal [Supplementary Fig. 17] or external sulfate [Fig. 5A -C] 299
demonstrate that SLC26A11 chloride channels are gated by SLC26A11 sulfate transport. 300
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
13
Discussion
301
The function of SLC26A11 has remained disputed. Cell -based assays have suggested that 302
the protein is either a pH-dependent secondary transporter for sulfate, chloride, and oxalate 303
1,5,6, or a channel for chloride 7-9. Here, by combining functional studies performed under well-304
defined conditions with single-particle cryo-EM and molecular dynamics simulations, we 305
demonstrate that human SLC26A11 can function as both a secondary -active transporter and 306
an anion channel. This dual -function behavior resolves the remaining controversy over the 307
function of SLC26A11 and provides the first insights into the mechanism of passive transport 308
in this family. 309
Our in vitro transport studies using membrane-rec onstituted protein indicate that SLC26A11 310
operates as an electroneutral proton:sulfate/chloride exchanger [Fig.1]. SLC26A11 thus 311
closely resembles the function of the rat lysosomal sulfate transporter reported three decades 312
ago 42. Together with its lysosomal localization 26,30 and its upregulation during lysosomal 313
biogenesis 27, our functional characterization suggests that SLC26A11 represents the elusive 314
lysosomal transporter for sulfate. Its use of the proton gradient as driving force to export sulfate 315
from the lysosome is consistent with other lysosomal transporters 37, e.g., SLC17A5 55, 316
SLC36A1 56, SLC46A3 57, SLC63A1 58, and SLC66A4 59. In agreement with its role as a 317
housekeeping protein, SLC26A11 shows a broad tissue distribution in the human body 6. 318
To function efficiently as a sulfate exporter, SLC26A11 must preferentially bind sulfate over 319
chloride. This is not trivial, as the lysosomal chloride concentrations are high (80 – 120 mM) 320
60,61 and exceed the lysosomal sulfate concentrations 40,41 by orders of magnitude. Our results 321
suggest that the molecular basis for this preferential binding of sulfate in the lysosomal lumen 322
is Glu-320. Glu-320 is the only amino acid in the membrane domain of SLC26A11 that is 323
predicted to have a pKa in the physiologically relevant range [Fig. 3C]. Within the mammalian 324
SLC26 family, SLC26A11 is the sole member with an acidic residue at this position [Fig. 3D]. 325
Glu-320 flanks the substrate binding site [Fig. 2], allowing it to contribute directly to the 326
electrochemical milieu of the binding site [Fig. 3E -F]. Protonation of Glu-320 increases the 327
binding affinity for sulfate from an apparent KD of 2.9 mM to 57 µM, whereas chloride binding 328
is essentially unaffected and remains at a comparably low affinity (apparent KD values of 6.0 329
mM and 5.3 mM at pH 7.5 and 5.0, respectively ) [Fig. 4]. Thus, Glu-320 acts as a signal 330
integration node that determines whether sulfate or chloride will be favored for transport [Fig. 331
4, Supplementary Fig. 13]. 332
Taken together, the following molecular mechanism for transport over the lysosomal 333
membrane emerges [Fig. 6]. At a lysosomal pH of approximately 4.6 33, Glu -320 is 334
predominantly protonated [Fig. 3C]. This selectively increases the binding affinity for sulfate 335
[Fig. 4B] and allows the formation of sulfate-bound SLC26A11 [Supplementary Fig. 20A] 336
despite the high lysosomal chloride concentration. While sulfate binding puts the protonated 337
carrier in a translocation -competent state that reorients efficiently [Fig. 1A, 1F], it is unclear 338
whether the chloride-bound protonated state is mobile. Efficient reorientation of this state 339
seems unlikely because the resulting proton leak would dissipate both the pH gradient and 340
the membrane potential, thereby disrupting lysosomal lumen homeostasis. After reorientation 341
of the sulfate-bound protonated binding site toward the cytoplasm, the neutral pH leads to 342
deprotonation of Glu-320 . This reduces the sulfate binding affinity and promotes sulfate 343
unbinding [Fig. 4B]. Sulfate rebinding is less favorable than chloride binding at this stage 344
[Supplementary Fig. 20B]. At low cytoplasmic chloride concentrations, a significant fraction 345
of the carrier remains in the apo state. Although deprotonated apo SLC26A11 appears to be 346
translocation competent, its reorientation seems much slower than that of the chloride-bound 347
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
14
state [Fig. 1A]. Finally, upon subsequent arrival in the lysosomal lumen, chloride is released 348
and Glu-320 is rapidly protonated, which may lock the carrier until a new sulfate ion is bound. 349
In addition to proton:sulfate/chloride exchange, heterologous expression and whole-cell patch 350
clamp assays assigned passive chloride currents to SLC26A11 [Fig. 5]. In principle, passive 351
currents can be conducted by ion channels, but also by transporters, i.e., by chloride 352
uniporters. Since SLC26A11 functions as a proton:sulfate/chloride exchanger, a 353
straightforward explanation for conductive chloride transport is a variation of the transport 354
cycle resulting in chloride uniport. For example, after chloride translocation, the transporter 355
could return to its initial conformation in the apo state instead of the proton- and sulfate-bound 356
state. However, the experimentally observed enhancement of chloride currents by conditions 357
favoring sulfate transport [Fig. 5; Supplementary Fig. 17] is incompatible with this uniport 358
mode of chloride transport. The co-existence of secondary active proton:sulfate/chloride 359
exchange and passive chloride currents activated by sulfate transport leaves little alternatives 360
to a channel-like conducting state in SLC26A11. 361
Figure 6: Model of the SLC26A11 dual-function mechanism. The SLC26A11 transport cycle can
be broken down in five steps. (Step 1) Protonation of Glu-320 in the lysosomal lumen allows (Step
2) selective binding of sulfate despite an excess of competing chloride. Upon reorientation of the
binding site to the cytoplasm, (Step 3) Glu-320 is deprotonated and (Step 4) sulfate unbinds. (Step
5) Subsequent binding of chloride accelerates the return of the substrate binding site to the lumen.
In the lysosomal lumen, ( Step 1’) chloride unbinds and Glu- 320 is rapidly protonated, thereby
completing the transport cycle. The formation of the channel -like, chloride-conducting state (Step *)
requires the binding of a proton (Step 1) and sulfate (Step 2) first. It may be reached following (Step
3) the subsequent release of the proton, thereby explaining the strong reduction in conductance of
the E320Q mutant, which permanently mimics the protonated state of Glu-320. Values for lysosomal
and cytoplasmic sulfate and chloride concentrations, pH, and membrane potential are based on
estimates 40,41 and published values 33,60-62. Representations of SLC26A11 with the substrate binding
site open to the lysosomal lumen or with a channel-like configuration are toy models.
Although membrane channels and transporters are traditionally considered to operate based 362
on fundamentally different structural and mechanistic principles 10,11, a few other transporter 363
families, i.e., SLC1 63-66, SLC6 67,68, and ClC-type transporters 69-71, have been shown to exhibit 364
a similar dual -function phenotype. Among these, members of the SLC1 family of excitatory 365
amino acid transporters have been studied in the most detail. Like SLC26 proteins, SLC1 366
proteins operate according to an elev ator-type transport mechanism, wherein a mobile 367
transport domain traverses the membrane relative to an immobile scaffold domain 72,73. In 368
SLC1 proteins, the anion-selective conduction pore is transiently formed at the interface 369
between the transport and scaffold domain 74,75. We presume that a similar mechanism 370
underlies channel formation in SLC26A11 [Fig. 6]. In SLC26A11, conductive states are 371
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
15
activated by conditions compatible with sulfate binding and transport [Fig. 5; Supplementary 372
Fig. 17]. The impaired chloride currents observed for the SLC26A11(E320Q) mutant, which 373
permanently mimics the protonated state and consequently binds sulfate with high affinity 374
regardless of the pH, suggest that the conductive state is formed after deprotonation but 375
before sulfate release [Fig. 6]. 376
While the relevance of sulfate export from the lysosome is apparent, the necessity of the 377
SLC26A11 chloride channel is not. In lysosomes, the Nernst potential for chloride is likely 378
close to the membrane potential 33. Thus, chloride fluxes over the SLC26A11 channel are 379
expected to be limited. However, if the luminal chloride concentration exceeds the range that 380
can be maintained by the membrane potential, the chloride conductance of SLC26A11 may 381
serve to decrease its value. Given the importance of chloride in accelerating the transport 382
mode, this feedback would ensure high transport rates. 383
Compared to its lysosomal counterpart, SLC26A11 residing in the plasma membrane is less 384
likely to reach the chloride-conductive state under physiological conditions. The neutral pH 385
and sub-millimolar sulfate concentrations on either side of the membrane 62,76 will suppress 386
the formation of the protonated and sulfate-bound state that precedes the chloride-conductive 387
conformation. However, consistent with its proposed role in pathological neuronal swelling in 388
brain edema 8, high SLC26A11 chloride currents are likely to occur during brain trauma and 389
ischemia due to the concomitant tissue acidification with external and internal pH values falling 390
below 6.5 77,78. 391
The subcellular localization of SLC26A11 is key to assess its impact on cellular physiology, 392
but how SLC26A11 trafficking is orchestrated remains unclear. SLC26A11 lacks typical 393
tyrosine or dileucine based lysosomal targeting s equences 79. Its appearance at the cell 394
surface suggests that it is first trafficked from the trans-Golgi network to the plasma membrane 395
and subsequently delivered to the lysos ome following internalization 80. However, the 396
efficiency of this process appears to vary between cell types, as SLC26A11 is not consistently 397
observed in the plasma membrane 30. Glycosylation does not affect the plasma membrane 398
localization of SLC26A11 53, in contrast to other lysosomal membrane proteins 81. 399
Alternatively, association with other membrane proteins may modulate transport between 400
compartments 82. While heterodimerization with other SLC26 proteins has been ruled out 30, 401
SLC26A11 has been shown to co- localize with the vacuolar -type H+-ATPase (V-ATPase) 1 402
and modulate its activity 7. Since the SLC26A11-STAS domain is remarkably compact and 403
lacks the disordered sequences typically used for protein -protein interactions in SLC26 404
proteins 4, the unique SH3 domain binding motif [Fig. 2D] between TM6 and the elongated 405
kinked TM7 may contribute to such an association with a lysosomal membrane protein. 406
In conclusion, our structural and functional characterization demonstrate that human 407
SLC26A11 is a dual -function protein that operates as both a coupled secondary transporter 408
for small anions and a chloride channel. The physiological relevance of these two modes 409
depend
s on the subcellular localization of the protein. SLC26A11 in lysosomes is the elusive 410
sulfate export system and its chloride conductance contributes to lysosomal chloride 411
homeostasis thereby ensuring high proton:sulfate/chloride exchange rates. Under 412
physiological conditions, the activity of plasmalemmal SLC26A11 is limited. Only upon tissue 413
acidification caused by, e.g., ischemia, SLC26A11 is activated as a chloride channel that 414
mediates anion influx and contributes to neuronal swelling 8. The proposed coupling of 415
SLC26A11 transport and anion channel opening implies that specific transport inhibitors, such 416
as a nanobody that binds to the extracellular face of SLC26A11, may contribute to a 417
therapeutic strategy to block chloride influx through SLC26A11 and prevent cytotoxic brain 418
edema caused by neuronal swelling. 419
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
16
Material/Methods 420
Molecular cloning of SLC26A11( ΔC) – The open reading frame of SLC26A11 was PCR 421
amplified from the pDONR221_SLC26A11 plasmid (Addgene: #131996) using FX-cloning 422
primers (https://www.fxcloning.org; for primer (5'-3'): 423
atatatgctcttctagtcccagctccgtgaccgccctgggacag, rev primer (5'-3'): 424
atatatgctcttctagtccaagctccgtgaccgccctggga). The column purified PCR product was cloned 425
into pINIT_cat (Addgene: #46858) u sing FX cloning 83. The Insert was sequence -verified, 426
subcloned into the pHXC3GS or pHXCA3GS vector and transformed into E. coli MC1061 for 427
plasmid production. 428
SLC26A11(ΔC, E320Q) mutagenesis – The open reading frame of SLC26A11 was PCR 429
amplified from the pDONR221_SLC26A11 plasmid (Addgene: #131996) in 2 separate PCR 430
reactions using the following primers: reaction 1 for primer (5' -3'): 431
atatatgctcttctagtcccagctccgtgaccgccctgggacag, reaction 1 rev primer (5'-3'): 432
atatatgctcttcattgcagcaggcccatcaggggcaccactgc, reaction 2 for primer (5'-3'): 433
atatatgctcttctcaatctatcgccgtggccaaggcctttgcc, reaction 2 rev primer (5'-3') : 434
atatatgctcttctagtccaagctccgtgaccgccctggga. PCR products of reaction 1 and 2 were column 435
purified, combined to equal molar ratio and cloned into pINIT_cat (Addgene: #46858) using 436
FX cloning. The insert was sequence-verified, subcloned into the pHXC3GS vector and 437
transformed into E. coli MC1061 for plasmid production. 438
SLC26A11 expression and purification – Baculovirus was prepared as described elsewhere 439
84 using the pHXC3GS or pHXCA3GS vectors harboring the SLC26A11(Δ C) open reading 440
frame. Trichoplusia ni cells at a concentration of 1x10 6 cells/mL were infected with 1% (v/v ) 441
baculovirus and cultivated in suspension for 72 h at 27 °C in ESF 921 serum -free medium. 442
Cells were collected by centrifugation at 300 x g and 4 °C for 10 minutes and resuspended in 443
20 mM Hepes pH 7.25, 150 mM NaCl, 10% glycerol, 1 mM PMSF, 1 mM MgCl 2, 2% DDM, 444
0.2% CHS and stirred for 1 h at 4 °C in presence of Benzonase. Cell debris was removed by 445
centrifugation at 140000 x g and 4 °C for 30 minutes. The supernatant was submitted to batch 446
binding with washed and pre-equilibrated Strep-Tactin® Superflow® resin (IBA) f or 1 h. The 447
sample was loaded on a gravity flow column, the column drained by gravity and the resin 448
washed with 20 column volumes wash buffer (20 mM Hepes pH 7.25, 150 mM NaCl, 10% 449
glycerol, 0.05% DDM, 0.005% CHS). SLC26A11 was eluted from the column by addition of 3 450
column volumes wash buffer supplemented with 2.5 mM D-desthiobiotin and subsequently 451
incubated for 1 h at 4 °C in presence of 1 mg HRV-3C protease. The sample was concentrated 452
at 2000 x g and 4 °C using an Amicon Ultra 50 kDa MWCO concentrator, centrifuged for 5 min 453
at 25,000 x g to remove large aggregates and subsequently loaded on a Superdex 200 454
increase 10/300 GL size exclusion column equilibrated with buffer containing 20 mM Hepes 455
pH 7.25, 150 mM NaCl, 0.05% DDM, 0.005% CHS. Peak fractions corresponding to dimeric 456
and monomeric SLC26A11 were pooled and diluted to 1 mg/ml concentration in 20 mM Hepes 457
pH 7.25, 150 mM NaCl, 10% glycerol, 0.05% DDM, 0.005% CHS, snap frozen in liquid 458
nitrogen and stored at -80°C until further use. 459
SLC26A11 for alpaca immunization was prepared in buffer containing a 10-fold higher CHS 460
concentration (20 mM Hepes pH 7.25, 150 mM NaCl, 10% glycerol, 0.05% DDM and 0.05% 461
CHS). For nanobody selection, SLC26A11 was expressed with a C -terminal AVI-tag and 462
enzymatically biotinylated as described elsewhere 85. Biotinylation efficiency was quantified 463
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
17
using the mobility shift of biotinylated protein in SDS -PAGE upon the addition of Streptavidin 464
and exceeded 90%. 465
Nanobody selection – Nb11 was selected against SLC26A11(ΔC) following the described 466
procedure 86,87. Two alpacas were immunized 4 times over a time course of 6 weeks. Four 467
days after the final antigen injection, peripheral blood lymphocytes were isolated. The RNA 468
was purified and converted to cDNA by reverse-transcription, the repertoire amplified by PCR 469
and nanobody genes were cloned into the phage display compatible pDX_init phagemid 88 470
(Addgene: #110101). Two rounds of phage display were performed, binders selected bas ed 471
on their ELISA-signal intensity and sequence analyzed. 472
MSP1E3D1 nanodisc reconstitution and cryoEM sample preparation – SLC26A11(ΔC) 473
was expressed and purified as described above but in the absence of CHS. Glycerol was 474
excluded from the wash and elution buffers. Affinity chromatography pure protein was mixed 475
with DDM solubilized SoyPC lipids in a 1:50 molar ratio and incubated for 1 h at 4 °C with 476
gentle agitation. MSP1E3D1 protein was added to a final molar ratio of 1:1:50 477
(SLC26A11(ΔC):MSP1E3D1:SoyPC) and the sample incubated for 5 h at 4 °C with gentle 478
agitation. Dried Bio-Beads SM -2 were added to a final amount of 50 mg beads/1 mg DDM. 479
The sample was incubated overnight at 4 °C with gentle agitation. Bio-Beads were removed 480
using a gravity column and the sample collected from the eluate. The SLC26A11(ΔC)-GFP 481
fusion protein was cleaved off for 1 h at 4 °C upon addition of 500 μg HRV-3C protease. The 482
sample was concentrated at 3000 x g and 4 °C using an Amicon Ultra 100 kDa MWCO 483
concentrator. The concentrated sample was centrifuged for 10 min at 13,000 x g to remove 484
large aggregates and subsequently loaded on a Superose 6 increase 10/300 GL size 485
exclusion column equilibrated with 20 mM Hepes pH 7.25, 150 mM NaCl. The main peak 486
fraction was applied to a second size exclusion run using the same column and buffer. The 487
main peak fraction was concentrated at 7000 x g and 4 °C using an Amicon Ultra 0.5 mL 50 488
kDa MWCO concentrator. Purified Nb11 was added to the size exclusion chromatography 489
pure SLC26A11(ΔC) nanodiscs in a 1:1.2 molar ratio and allowed to bind for 1 h at 4 °C before 490
freezing. 491
Proteoliposome preparation – Purified SLC26A11(ΔC) was mixed with preformed, Triton X-492
100 destabilized large unilamellar vesicles from SoyPC and DDM solubilized BMP lipid to a 493
ratio of 1:50:0.5 (wt/wt/wt) SLC26A11:SoyPC:BMP (LPR 50) and incubated 15 min at room 494
temperature. Detergent was removed from the sample by stepwise addition of Bio Beads SM-495
2 as described previously 89. Bio Beads were removed from the sample using a gravity column. 496
Proteoliposomes were collected by centrifugation for 1 h at 140000 x g and resuspended to 497
20 mg lipid/mL concentration in 50 mM KPi pH 7.5 using a 25-gauge needle and snap frozen 498
and stored in liquid nitrogen until further use. 499
Radioisotope transport assays – Proteoliposomes were thawed, centrifuged at 250000 x g 500
and 15 °C for 20 minutes and resuspended in buffer containing 20 mM Hepes, 20 mM Mes 501
pH 7.5, 2 mM Mg-gluconate and 50 mM KCl. Proteoliposomes were snap frozen in liquid 502
nitrogen and thawed at room temperature three times before 11x extrusion using a 400 nm 503
polycarbonate filter. Proteoliposomes were centrifuged at 250000 x g and 15 °C for 20 504
minutes, the supernatant discarded and the pellet resuspended to 100 mg/ml concentration in 505
buffer containing 20 mM Hepes, 20 mM Mes pH 7.5, 2 mM Mg-gluconate and 50 mM KCl and 506
homogenized with a 25-gauge needle. To initiate transport, proteoliposomes were diluted to 507
2.5 mg/ml concentration in 30 °C warm buffer containing 20 mM Hepes, 20 mM Mes pH 5, 50 508
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
18
mM K-gluconate, 2 mM Mg-gluconate and 50 μ M K2SO4 with 2 μCi/ml activity. The transport 509
reaction was performed in a water bath at 30 °C and stopped at regular intervals by 20-fold 510
dilution of a 100 µl aliquot in ice-cold uptake buffer followed by rapid filtration on 0.45 µm 511
nitrocellulose filters. Filters were washed with additional 2 ml buffer, d issolved overnight in 512
4 ml Ultima Gold TM LSC cocktail (SigmaAldrich) and analyzed using a Tri-carb 2900TR 513
(PerkinElmer) liquid scintillation counter. 514
Cryo-EM methods – Samples were vitrified on UltrAuFoil grids (R0.6/1.0, Quantifoil, 515
Germany) after glow discharge for 150 sec in air at a pressure of 3.0x10 -1 Torr at medium 516
power with a Harrick Plasma Cleaner (PDC-002). A Vitrobot IV (ThermoFisher ) was used for 517
vitrification in liquid ethane with 5 s blot time and +20 blot force. Movie data was acquired at 518
the cryo-EM facility in Würzburg on a Krios G3 electron microscope (ThermoFisher) with 519
different cameras and settings for the two samples: For SLC26A11 with Nb11 a Falcon III 520
direct detector was used in counting mode, collecting 47 fractions in 75 sec. At a magnification 521
of 75,000x a calibrated pixel size of 1.0635 Å was obtained and a total exposure of 522
79 electrons/Å2 was used. The target defocus range was between 1.0 to 1.4 µm under focus. 523
2553 movies were recorded and then motion corrected and dose weighted in a live session of 524
the program package cryoSPARC version 4.4 90 followed by patch based CTF estimation. All 525
subsequent steps of image processing were also performed in cryoSPARC . The initial set of 526
1,325,543 particles were obtained with a blob picker and cleaned up by 2D classification to 527
570,899 particles. Three initial volumes were obtained by an ab-initio reconstruction. The initial 528
volumes were used in a heterogeneous refinement as starting references. One of the resulting 529
classes with 276,124 particles was further refined in a non-uniform refinement with C1 530
symmetry and used as input for a variability analysis with three principal components 531
subdividing the data set into three clusters. One of three clusters with 48,803 particles was 532
then analysed in another non-uniform refinement with applied C2 symmetry and reached a 533
resolution of 3.2 Å. 534
For SLC26A11 with Nb4, a Falcon IVi direct detector attached to a Selectris energy filter was 535
used. Movies were recorded as zero-loss images with a slit width of 5 eV. A magnification of 536
130,000x resulted in a calibrated pixel size of 0.946 Å and a total exposure of 70 electrons/Å2 537
was used with an exposure time of 6.2 s. The target defocus range was between 0.6 and 538
1.6 µm under focus. 11086 movies were recorded in EER format. Further image analysis was 539
performed with cryoSPARC. The EER movies were converted into 40 fractions, followed by 540
motion correction, dose weighting and averaging of the fractions. The CTF of the averaged 541
fractions was estimated with patch ctf. Initially, 2,147,241 particles were picked with a blob 542
picker and reduced to 115,117 particles by 2D classification keeping particles in classes with 543
the best-defined class averages. Three initial volumes were determined in an ab-initio 544
reconstruction. These volumes were used as starting references in a heterogeneous 545
refinement. The classes were further refined by non-uniform refinement. One of the classes 546
provided a 3D-map, which was projected equally in space to create templates for template 547
picking. Template picking identified 3,616,816 particles which were reduced to 457,309 548
particles by 2D-classification and selection of the best 2D-classes. The selected particles were 549
analysed by another round of heterogeneous refinement. One of the classes of the 550
heterogeneous refinement with 210,771 particles was subjected to non-uniform refinement 551
with imposed C2-symmetry. This resulted in a map with 2.8 Å resolution, which was then 552
filtered according to the local resolution. 553
An initial atomic model of the map was obtained with the program Modelangelo 91. The 554
model was manually optimised using Coot version 0.9.8.93 92,93 and ChimeraX/ISOLDE 94 555
and refined with the real-space refinement tool of Phenix version 1.21.1 95. 556
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
19
Differential scanning fluorometry – SLC26A11(ΔC) was dialyzed 3 times 30 minutes at 4 °C 557
against buffer containing 20 mM Hepes pH 7.25, 0.05% DDM to remove chloride ions from 558
the sample. The protein was diluted to 0.1 mg/ml final concentration in buffer containing 559
100 mM Hepes, 100 mM MES, pH 7.5 or pH 5.0, respectively, with 80 mM of the tested anion 560
as sodium salt and 70 mM sodium gluconate. For affinity determination of sulfate or chloride, 561
respectively, titration of the tested anion starting from 80 mM was performed and the total 562
anion concentration kept constant at 150 mM by addition of additional sodium gluconate. 563
Samples were equilibrated for 30 minutes on ice, 15 minutes at room temperature and 564
subjected to thermal melting in triplicates from 20 to 70 °C with a ramp of 1 °C/min using a 565
Prometheus NT.48 (Nanotemper) at 100% gain and Prometheus standard capillaries. The 566
melting curves were analyzed and Tm values calculated with the PR. StabilityAnalysis 567
software (Nanotemper). For affinity determination, ΔTm/Tm Apo was plotted against the anion 568
concentration and a non-linear curve fit performed in OriginPro using equation 1 as described 569
elsewhere 96,97: 570
equation 1)
𝛥𝛥𝛥𝛥𝛥𝛥
𝛥𝛥
𝛥𝛥𝐴𝐴𝐴𝐴𝐴𝐴
(𝐿𝐿) =
−𝑅𝑅𝛥𝛥𝑠𝑠𝑠𝑠𝑠𝑠
𝐸𝐸𝑎𝑎1
∗ ln �
𝐾𝐾𝐷𝐷
𝐾𝐾𝐷𝐷+𝐿𝐿 � 571
where L is the total ligand concentration; R is the universal gas constant; T std is the standard 572
temperature (298.15 K); Ea1 the activation energy of apo state unfolding. 573
For affinity determination of anions other than chloride or sulfate, ΔTm/TmApo was derived from 574
thermal melting in presence of 80 mM substrate concentration and the dissociation constant 575
calculated using equation 2 with E a1 derived from sulfate/chloride titration as descr ibed 576
elsewhere 97: 577
equation 2) 𝐾𝐾𝐷𝐷=
𝐿𝐿
𝑒𝑒
� 𝛥𝛥𝛥𝛥𝛥𝛥
𝛥𝛥 𝛥𝛥𝐴𝐴
𝐴𝐴𝐴𝐴
∗𝐸𝐸𝑎𝑎1
𝑅𝑅 𝛥𝛥�
−1
578
579
Molecular dynamics simulations – The final coordinates of the SLC26A11 structure were 580
used for all -atom molecular dynamics (MD) simulations. We modelled residues 26– 583, 581
neutralizing the artificial N- and C -termini using acetylation and n-methylamidation 582
respectively using VMD 98. MD simulations and analysis were performed using GROMACS 583
2022 99. An additional system was generated with glutamate 320 protonated (E320p); the 584
protonation, remaining hydrogen atoms, and topologies were generated using gmx pdb2gmx. 585
The protein was embedded in a membrane containing 1-palmitoyl -2-oleoyl-glycero-3-586
phosphocholine (POPC) using gmx membed. The initial system was solvated (TIP3P) and 587
ionized with 200 mM NaCl, with subsequent neutralization. The protein was modelled using 588
the CHARMM36m force-field, lipids, water, and Na+/Cl- ions were modelled with CHARMM36. 589
For sulfate, we took the initial parameters from Cannon et al. 100, with the addition of a non-590
bonded coefficient alteration (CUFIX) 101 to account for sulfate-protein interactions. To 591
increase the possibility of sulfate binding we removed all chlorides, and added 15 molecules 592
of SO42–, resulting in a final concentration of ~ 10 mM Na 2SO4 after neutralization. We used 593
the following minimization/equilibration protocol for the E320 (deprotonated system) with 200 594
mM NaCl: After embedding, the protein was minimized using the steepest descent algorithm 595
(step 1), followed by 50 ns of simulation with position restraints on all atoms except for lipid 596
heavy atoms in the XY plane (step 2.0). The next 50 ns step had position restraints only on 597
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
20
the protein (step 2.1), and finally 50 ns with only protein backbone restraints (step 2.2). 598
Equilibration was monitored via the number of protein-lipid contacts. All simulations are 599
performed under the NPT ensemble, with v-rescale 102, and c-rescale 103 for temperature and 600
pressure coupling respectively. Protonated systems (E320p), and systems containing Na2SO4 601
were constructed from the final frame of step 2.1, i.e., added proton and/or replaced 200 mM 602
NaCl with 10 mM Na2SO4, followed by step 2.2 for each additional system – equilibration was 603
monitored for each system separately. The final 10 ns of step 2.2 were used to initiate three 604
replicates for the Na 2SO4 containing systems, and six replicates for the NaCl systems, each 605
replicate being run for a minimum of 700 ns totalling roughly 15 µs. 606
Computational predictions of pK a – To approximate the pK a values for titratable residues, 607
propkatraj 104 was used. Due to the heuristic approach of PROPKA 3.1 105, the underlying 608
algorithm in propkatraj, pKa predictions from individual conformations are subject to significant 609
variance, and lack accuracy – propkatraj helps to ameliorate this issue by estimating the pK a 610
for many frames (1frame/ns for ~6500 ns), resulting in distributions of pK a, centred around a 611
mean-value. These average pKa values were reported in Figure 3B. 612
Biophysical characterization of the anion binding pocket (ABP ) – To dissect the 613
molecular interactions between chloride, sulfate, and the ABP, electrostatics of the ABP, and 614
kinetics/thermodynamics of the anion– ABP interactions were evaluated 106. Full system 615
electrostatics were calculated using g_elpot 107, which evaluates the electrostatic potential felt 616
by water molecules. To this end, a sphere with a radius of 7 Å, centred at the ABP was 617
coloured according to the electrostatic potential at the surface of the sphere [Fig. 3E, F]. 618
To evaluate the kinetics of binding, we define the inner- and outer-boundary of 14 Å and 15 Å 619
respectively, as the boundaries of a Schmitt- Trigger which filters out noise at the ABP 620
entrance. We define anion binding according to a single- ion radial distribution function to the 621
ABP center of geometry. The distance of 14 Å represents the first contact that the anion makes 622
within the intracellular vestibule of SLC26A11. When an anion was within 14 Å of the ABP 623
center of geometry, it was considered bound (1), whereas distances greater than 15 Å were 624
considered unbound (0). When the distance is the range 14-15 Å, the bound state (1 or 0) is 625
determined by the previous bound state. The state-trajectories are separated into 𝑁𝑁𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 626
groups of consecutive 1’s, where 𝑁𝑁𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 is the number of binding events. 627
equation 3)
628
equation 4)
629
equation 5)
630
equation 6)
631
equation 7) 𝐾𝐾𝐷𝐷=
𝑘𝑘𝑂𝑂𝑂𝑂𝑂𝑂
𝑘𝑘𝑂𝑂𝑂𝑂
632
Here,
is the average dwell-time, 𝐿𝐿 is the length of a consecutive group of 1’s, and
is 633
the time-step of the state-trajectory, which is 0.1 ns for all systems. Similarly,
, and 634
consequently 𝑘𝑘𝐵𝐵𝐵𝐵 can be calculated similarly by evaluating 𝑁𝑁𝐵𝐵𝐵𝐵𝑢𝑢𝐵𝐵𝐵𝐵 𝐵𝐵𝐵𝐵 consecutive groups of 0’s 635
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
21
from the state-trajectory. Since 𝑘𝑘𝐵𝐵𝐵𝐵 is a second order rate-constant, we normalized it to the 636
bulk concentration of chloride (0.2 M) and sulfate (0.009 M) respectively. 637
Electrophysiology – For electrophysiological characterization, wild type and mutant 638
hSLC26A11 fused to GFP was expressed in Sf 9 insect cells (Spodoptera frugiperda) and 639
tested 2-5 days after infection with 1% (v/v) baculovirus . Standard whole-cell patch cl amp 640
recordings were performed with an EPC-10 USB amplifier (HEKA Elektronik, Göttingen) with 641
pipette resistances between 3-5 MΩ as described 108,109. Cells were clamped to 0 mV for at 642
least 5 s between test sweeps, and voltage pulses were applied for 150 ms from -120 mV to 643
+60 mV in 15 mV steps. Junction potentials were corrected a priori. For the recordings shown 644
in [Fig. 5b], external solutions contained 128.5 mM NaCl, 7.5 mM Na-gluconate, 1 mM MgCl2, 645
5 mM CaCl2, 5 mM TEA-Cl, 10 mM HEPES/Tris, pH 7, or 5 mM HEPES/5 mM MES, pH 6. 646
The pipette internal solution contained 150 mM KCl, 0.5 mM K2SO4, 2 mM MgCl2, 5 mM EGTA 647
and 10 mM HEPES/KOH, pH 8.5. Anion selectivity [Supplementary Fig. 18] was tested by 648
external perfusion of cells with solutions containing 0.5 mM Na2SO4 in combination with 145 649
mM Cl- (128 mM NaCl, 0.5 mM Na2SO4, 1 mM MgCl2, 5 mM CaCl2, 5 mM TEA-Cl, 10 mM 650
HEPES/Tris pH 8.5), 5 mM Cl- (128 mM Na-gluconate, 0.5 mM Na2SO4, 1 mM Mg-gluconate, 651
5 mM Ca-gluconate, 5 mM TEA-Cl, 10 mM HEPES/Tris, pH 8.5) or 147 mM SCN- (147 mM 652
NaSCN, 0.5 mM Na2SO4, 1 mM MgCl2, 5 mM CaCl2, 5 mM TEA-Cl, 10 mM HEPES/Tris, pH 653
8.5) at pH 7, with an internal solution containing 120 mM KCl, 10 mM K2SO4 , 2 mM MgCl2, 5 654
mM
EGTA, 5 mM MES/5 mM HEPES/KOH, pH 6.0. For the pH dependences 655
[Supplementary Fig. 19] the external solutions contained 128 mM NaCl, 10 mM Na2SO4, 1 656
mM MgCl 2, 5 mM CaCl2, 5 mM TEA-Cl, buffered with 10 mM HEPES/Tris and MES/Tris 657
mixtures to pH 7.33/pH 7.0/pH 6.66/pH 6.33/pH 6.0. The internal solution contained 150 mM 658
KCl, 0.5 mM K2SO4, 2 mM MgCl2, 5 mM EGTA, 10 mM HEPES/Tris, pH 7.33). 659
Data availability – All raw data are available upon request. The python script used in the 660
calculation of kinetic constants from MD simulations is available at h ttps://jugit.fz-661
juelich.de/computational-neurophysiology/SLC26A11-ion-binding. 662
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
22
Acknowledgements
663
We would like to thank Barbara Borgonovo, Aliona Bogdanova, and Régis Lemaitre from the 664
Protein Biochemistry facility of the MPI-CBG for their support. We further thank Sasa Stefanic 665
from the Nanobody Service facility of the University of Zurich for his ongoing support. We 666
acknowledge past and present members of FOR5046 for stimulating discussions and critical 667
feedback. We further acknowledge Michele Marass for corrections to the manuscript. This 668
work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research 669
Foundation) as part of Research Unit 5046 (FOR5046; project 426950122) to E.R.G. 670
(subproject P1), J.-P.M. (subproject P2), as well as to ChF (subproject P4), and projects 671
359471283, 456578072, 525040890 (EM facility Würzburg; BB ). The authors gratefully 672
acknowledge computing time on the supercomputer JURECA at Forschungszentrum Jülich 673
under grant jara0177. All members of the Geertsma lab are acknowledged for help in all stages 674
of the project. 675
Author contributions 676
B.T.K., J.-P.M., Ch.F., and E.R.G. conceived the project. B.T.K. performed all protein 677
biochemistry, carried out reconstitutions in proteoliposomes and nanodiscs, performed in vitro 678
transport studies and binding assays, and selected nanobodies under the supervision of 679
E.R.G. P.K. performed electrophysiological characterization of SLC26A11 in insect cells with 680
the help of S.B.-G., using baculovirus provided by B.T.K, and under the supervision of Ch.F. 681
B.G.H. performed molecular dynamics simulations, pKa predictions, electrostatic 682
characterization, and kinetic analysis of ion binding under the supervision of J.-P.M. T.R. 683
prepared grids, recorded, and processed cryo-EM data with the help of T.H. and under the 684
supervision of B.B. T.R., T.H. and B.T.K. built and validated cryo-EM stru ctures. All authors 685
discussed and analyzed the results. B.T.K. and E.R.G. wrote the first draft of the manuscript 686
with contributions from all authors. All authors participated in the revision of the manuscript. 687
688
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
23
References
689
1. Xu, J. et al. Slc26a11, a chloride transporter, localizes with the vacuolar H(+)-ATPase 690
of A-intercalated cells of the kidney. Kidney Int 80, 926-937 (2011). 691
2. Karlsson, M. et al. A single-cell type transcriptomics map of human tissues. Sci Adv 692
7(2021). 693
3. Alper, S.L. & Sharma, A.K. The SLC26 gene family of anion transporters and channels. 694
Mol Aspects Med 34, 494-515 (2013). 695
4. Geertsma, E.R. & Oliver, D. SLC26 Anion Transporters. Handb Exp Pharmacol 283, 696
319-360 (2024). 697
5. Stewart, A.K. et al. SLC26 anion exchangers of guinea pig pancreatic duct: molecular 698
cloning and functional characterization. Am J Physiol Cell Physiol 301, C289-303 699
(2011). 700
6. Vincourt, J.B., Jullien, D., Amalric, F. & Girard, J.P. Molecular and functional 701
characterization of SLC26A11, a sodium -independent sulfate transporter from high 702
endothelial venules. Faseb j 17, 890-2 (2003). 703
7. Rahmati, N. et al. Slc26a11 is prominently expressed in the brain and functions as a 704
chloride channel: expression in Purkinje cells and stimulation of V H⁺-ATPase. Pflugers 705
Arch 465, 1583-97 (2013). 706
8. Rungta, R.L. et al. The cellular mechanisms of neuronal swelling underlying cytotoxic 707
edema. Cell 161, 610-621 (2015). 708
9. Wei, S. et al. SLC26A11 Inhibition Reduces Oncotic Neuronal Death and Attenuates 709
Stroke Reperfusion Injury. Molecular Neurobiology (2023). 710
10. Gadsby, D.C. Ion channels versus ion pumps: the principal difference, in principle. Nat 711
Rev Mol Cell Biol 10, 344-52 (2009). 712
11. Drew, D. & Boudker, O. Shared Molecular Mechanisms of Membrane Transporters. 713
Annual Review of Biochemistry 85, 543-572 (2016). 714
12. Liu, Q. et al. Asymmetric pendrin homodimer reveals its molecular mechanism as 715
anion exchanger. Nat Commun 14, 3012 (2023). 716
13. Geertsma, E.R. et al. Structure of a prokaryotic fumarate transporter reveals the 717
architecture of the SLC26 family. Nat Struct Mol Biol 22, 803-8 (2015). 718
14. Wang, L., Chen, K. & Zhou, M. Structure and function of an Arabidopsis thaliana sulfate 719
transporter. Nat Commun 12, 4455 (2021). 720
15. Tippett, D.N., Breen, C., Butler, S.J., Sawicka, M. & Dutzler, R. Structural and 721
functional properties of the transporter SLC26A6 reveal mechanism of coupled anion 722
exchange. Elife 12(2023). 723
16. Ishii, J. et al. Congenital goitrous hypothyroidism is caused by dysfunction of the iodide 724
transporter SLC26A7. C ommun Biol 2, 270 (2019). 725
17. Kim, K.H., Shcheynikov, N., Wang, Y. & Muallem, S. SLC26A7 is a Cl - channel 726
regulated by intracellular pH. J Biol Chem 280, 6463-70 (2005). 727
18. Kosiek, O. et al. SLC26A7 can function as a chloride-loading mechanism in parietal 728
cells. Pflugers Arch 454, 989-98 (2007). 729
19. Schanzler, M. & Fahlke, C. Anion transport by the cochlear motor protein prestin. J 730
Physiol 590, 259-72 (2012). 731
20. Chang, M.H. et al. Slc26a9--anion exchanger, channel and Na+ transporter. J Membr 732
Biol 228, 125-40 (2009). 733
21. Dorwart, M.R., Shcheynikov, N., Wang, Y., Stippec, S. & Muallem, S. SLC26A9 is a 734
Cl(-) channel regulated by the WNK kinases. J Physiol 584, 333-45 (2007). 735
22. Loriol, C. et al. Characterization of SLC26A9, facilitation of Cl( -) transport by 736
bicarbonate. Cell Physiol Biochem 22, 15-30 (2008). 737
23. Bertrand, C.A., Zhang, R., Pilewski, J.M. & Frizzell, R.A. SLC26A9 is a constitutively 738
active, CFTR -regulated anion conductance in human bronchial epithelia. J Gen 739
Physiol 133, 421-38 (2009). 740
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
24
24. Walter, J.D., Sawicka, M. & Dutzler, R. Cryo-EM structures and functional 741
characterization of murine Slc26a9 reveal mechanism of uncoupled chloride transport. 742
eLife 8, e46986 (2019). 743
25. Chapel, A. et al. An extended proteome map of the lysosomal membrane reveals novel 744
potential transporters. Mol Cell Proteomics 12, 1572-88 (2013). 745
26. Schroder, B.A., Wrocklage, C., Hasilik, A. & Saftig, P. The proteome of lysosomes. 746
Proteomics 10, 4053-76 (2010). 747
27. Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. 748
Science 325, 473-7 (2009). 749
28. Palmieri, M. et al. Characterization of the CLEAR network reveals an integrated control 750
of cellular clearance pathways. Hum Mol Genet 20, 3852-66 (2011). 751
29. Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 752
1429-33 (2011). 753
30. Bungert-Plümke, S., Guzman, R.E. & Fahlke, C. Oligomerization and cellular 754
localization of SLC26A11. bioRxiv, 2024.04.29.591613 (2024). 755
31. Saftig, P. & Klumperman, J. Lysosome biogenesis and lysosomal membrane proteins: 756
trafficking meets function. Nat Rev Mol Cell Biol 10, 623-35 (2009). 757
32. Parenti, G., Medina, D.L. & Ballabio, A. The rapidly evolving view of lysosomal storage 758
diseases. EMBO Mol Med 13, e12836 (2021). 759
33. Xu, H. & Ren, D. Lysosomal physiology. Annu Rev Physiol 77, 57-80 (2015). 760
34. Huizing, M. & Gahl, W.A. Inherited disorders of lysosomal membrane transporters. 761
Biochim Biophys Acta Biomembr 1862, 183336 (2020). 762
35. Sagne, C. & Gasnier, B. Molecular physiology and pathophysiology of lysosomal 763
membrane transporters. J Inherit Metab Dis 31, 258-66 (2008). 764
36. Platt, F.M., d'Azzo, A., Davidson, B.L., Neufeld, E.F. & Tifft, C.J. Lysosomal storage 765
diseases. Nat Rev Dis Primers 4, 27 (2018). 766
37. Ruivo, R., Anne, C., Sagne, C. & Gasnier, B. Molecular and cellular basis of lysosomal 767
transmembrane protein dysfunction. Biochim Biophys Acta 1793, 636-49 (2009). 768
38. Diez-Roux, G. & Ballabio, A. Sulfatases and human disease. Annu Rev Genomics 769
Hum Genet 6, 355-79 (2005). 770
39. Rome, L.H. & Hill, D.F. Lysosomal degradation of glycoproteins and 771
glycosaminoglycans. Efflux and recycling of sulphate and N -acetylhexosamines. 772
Biochem J 235, 707-13 (1986). 773
40. Frese, M.A., Schulz, S. & Dierks, T. Arylsulfatase G, a novel lysosomal sulfatase. J 774
Biol Chem 283, 11388-95 (2008). 775
41. Wi egmann, E.M. et al. Arylsulfatase K, a novel lysosomal sulfatase. J Biol Chem 288, 776
30019-30028 (2013). 777
42. Jonas, A.J. & Jobe, H. Sulfate transport by rat liver lysosomes. J Biol Chem 265, 778
17545-9 (1990). 779
43. Rahmati, N. et al. SLC26A11 (KBAT) in Purkinje Cells Is Critical for Inhibitory 780
Transmission and Contributes to Locomotor Coordination. eNeuro 3(2016). 781
44. Chang, Y.N. & Geertsma, E.R. The novel class of seven transmembrane segment 782
inverted repeat carriers. Biol Chem 398, 165-174 (2017). 783
45. Kuhn, B.T. et al. Interdomain-linkers control conformational transitions in the SLC23 784
elevator transporter UraA. Nat Commun 15, 7518 (2024). 785
46. Hu, W., Song, A. & Zheng, H. Substrate binding plasticity revealed by Cryo-EM 786
structures of SLC26A2. Nat Commun 15, 3616 (2024). 787
47. Wang, L. et al. Mechanism of anion exchange and small-molecule inhibition of pendrin. 788
Nat Commun 15, 346 (2024). 789
48. Butan, C. et al. Single particle cryo- EM structure of the outer hair cell motor protein 790
prestin. Nat Commun 13, 290 (2022). 791
49. Futamata, H. et al. Cryo-EM structures of thermostabilized prestin provide mechanistic 792
insights underlying outer hair cell electromotility. Nat Commun 13, 6208 (2022). 793
50. Ge, J. et al. Molecular mechanism of prestin electromotive signal amplification. Cell 794
184, 4669-4679 e13 (2021). 795
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
25
51. Chi, X. et al. Structural insights into the gating mechanism of human SLC26A9 796
mediated by its C-terminal sequence. Cell Discovery 6, 55 (2020). 797
52. Li, X.R., Chi, X.M., Zhang, Y.Y., Zhou, Q. 8IET. (2024). 798
53. Li, J., Xia, F. & Reithmeier, R.A. N -glycosylation and topology of the human SLC2 6 799
family of anion transport membrane proteins. Am J Physiol Cell Physiol 306, C943-60 800
(2014). 801
54. Teyra, J. et al. Comprehensive Analysis of the Human SH3 Domain Family Reveals a 802
Wide Variety of Non-canonical Specificities. Structure 25, 1598-1610 e3 (2017). 803
55. Schmiege, P., Donnelly, L., Elghobashi-Meinhardt, N., Lee, C.H. & Li, X. Structure and 804
inhibition of the human lysosomal transporter Sialin. Nat Commun 15, 4386 (2024). 805
56. Sagne, C. et al. Identification and characterization of a lysosomal transporter for small 806
neutral amino acids. Proc Natl Acad Sci U S A 98, 7206-11 (2001). 807
57. Tomabechi, R. et al. SLC46A3 is a lysosomal proton-coupled steroid conjugate and 808
bile acid transporter involved in transport of active catabolites of T-DM1. PNAS Nexus 809
1, pgac063 (2022). 810
58. He, M. et al. Spns1 is a lysophospholipid transporter mediating lysosomal phospholipid 811
salvage. Proc Natl Acad Sci U S A 119, e2210353119 (2022). 812
59. Lobel, M. et al. Structural basis for proton coupled cystine transport by cystinosin. Nat 813
Commun 13, 4845 (2022). 814
60. Stauber, T. & Jentsch, T.J. Chloride in vesicular trafficking and function. Annu Rev 815
Physiol 75, 453-77 (2013). 816
61. Chakraborty, K., Leung, K. & Krishnan, Y. High lumenal chloride in the lysosome is 817
critical for lysosome function. Elife 6(2017). 818
62. Mohapatra, N.K. et al. Sulfate concentrations and transport in human bronchial 819
epithelial cells. Am J Physiol 264, C1231-7 (1993). 820
63. Fairman, W.A., Vandenberg, R.J., Arriza, J.L., Kavanaugh, M.P. & Amara, S.G. An 821
excitatory amino-acid transporter with properties of a ligand-gated chloride channel. 822
Nature 375, 599-603 (1995). 823
64. Wadiche, J.I., Amara, S.G. & Kavanaugh, M.P. Ion fluxes associated with excitatory 824
amino acid transport. Neuron 15, 721-8 (1995). 825
65. Ryan, R.M. & Mindell, J.A. The uncoupled chloride conductance of a bacterial 826
glutamate transporter homolog. Nat Struct Mol Biol 14, 365-71 (2007). 827
66. Kolen, B. et al. Vesicular glutamate transporters are H(+) -anion exchangers that 828
operate at variable stoichiometry. Nat Commun 14, 2723 (2023). 829
67. Mager, S. et al. Conducting states of a mammalian serotonin transporter. Neuron 12, 830
845
-59 (1994). 831
68. Schicker, K. et al. Unifying concept of serotonin transporter-associated currents. J Biol 832
Chem 287, 438-445 (2012). 833
69. Accardi, A. & Miller, C. Secondary active transport mediated by a prokaryotic 834
homologue of ClC Cl- channels. Nature 427, 803-7 (2004). 835
70. Zdebik, A.A. et al. Determinants of anion-proton coupling in mammalian endosomal 836
CLC proteins. J Biol Chem 283, 4219-27 (2008). 837
71. Alekov, A.K. & Fahlke, C. Channel -like slippage modes in the human anion/proton 838
exchanger ClC-4. J Gen Physiol 133, 485-96 (2009). 839
72. Crisman, T.J., Qu, S., Kanner, B.I. & Forrest, L.R. Inward-facing conformation of 840
glutamate transporters as revealed by their inverted-topology structural repeats. Proc 841
Natl Acad Sci U S A 106, 20752-7 (2009). 842
73. Reyes, N., Ginter, C. & Boudker, O. Transport mechanism of a bacterial homologue of 843
glutamate transporters. Nature 462, 880-5 (2009). 844
74. Machtens, J.P. et al. Mechanisms of anion conduction by coupled glutamate 845
transporters. Cell 160, 542-53 (2015). 846
75. Chen, I. et al. Glutamate transporters have a chloride channel with two hydrophobic 847
gates. Nature 591, 327-331 (2021). 848
76. Cole, D.E. & Evrovski, J. Quantitation of sulfate and thiosulfate in clinical samples by 849
ion chromatography. J Chromatogr A 789, 221-32 (1997). 850
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
26
77. Farkas, E. & Rose, C.R. A dangerous liaison: Spreading depolarization and tissue 851
acidification in cerebral ischemia. J Cereb Blood Flow Metab 45, 201-218 (2025). 852
78. Maruki, Y., Koehler, R.C., Eleff, S.M. & Traystman, R.J. Intracellular pH during 853
reperfusion influences evoked potential recovery after complete cerebral ischemia. 854
Stroke 24, 697-703; discussion 704 (1993). 855
79. Bonifacino, J.S. & Traub, L.M. Signals for sorting of transmembrane proteins to 856
endosomes and lysosomes. Annu Rev Biochem 72, 395-447 (2003). 857
80. Braulke, T. & Bonifacino, J.S. Sorting of lysosomal proteins. Biochim Biophys Acta 858
1793, 605-14 (2009). 859
81. Lang, C.M. et al. Membrane orientation and subcellular localization of transmembrane 860
protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration. 861
J Biol Chem 287, 19355-65 (2012). 862
82. Staudt, C., Puissant, E. & Boonen, M. Subcellular Trafficking of Mammalian Lysosomal 863
Proteins: An Extended View. Int J Mol Sci 18(2016). 864
83. Geertsma, E.R. & Dutzler, R. A versatile and efficient high-throughput cloning tool for 865
structural biology. Biochemistry 50, 3272-8 (2011). 866
84. Lemaitre, R.P., Bogdanova, A., Borgonovo, B., Woodruff, J.B. & Drechsel, D.N. 867
FlexiBAC: a versatile, open-source baculovirus vector system for protein expression, 868
secretion, and proteolytic processing. BMC Biotechnol 19, 20 (2019). 869
85. Kuhn, B.T. et al. Biotinylation of Membrane Proteins for Binder Selections. Methods 870
Mol Biol 2127, 151-165 (2020). 871
86. Pardon, E. et al. A general protocol for the generation of Nanobodies for structural 872
biology. Nat Protoc 9, 674-93 (2014). 873
87. Zimmermann, I. et al. Synthetic single domain antibodies for the conformational 874
trapping of membrane proteins. Elife 7(2018). 875
88. Zimmermann, I. et al. Generation of synthetic nanobodies against delicate proteins. 876
Nat Protoc 15, 1707-1741 (2020). 877
89. Geertsma, E.R., Nik Mahmood, N.A., Schuurman-Wolters, G.K. & Poolman, B. 878
Membrane reconstitution of ABC transporters and assays of translocator function. Nat 879
Protoc 3, 256-66 (2008). 880
90. Punjani, A., Rubinstein, J.L., Fleet, D.J. & Brubaker, M.A. cryoSPARC: algorithms for 881
rapid unsupervised cryo-EM structure determination. Nat Methods 14, 290-296 (2017). 882
91. Jamali, K. et al. Automated model building and protein identification in cryo-EM maps. 883
Nature 628, 450-457 (2024). 884
92. Brown, A. et al. Tools for macromolecular model building and refinement into electron 885
cryo-microscopy reconstructions. Acta Crystallogr D Biol Crystallogr 71, 136-53 886
(
2015). 887
93. Emsley, P., Lohkamp, B., Scott, W.G. & Cowtan, K. Features and development of 888
Coot. Acta Crystallogr D Biol Crystallogr 66, 486-501 (2010). 889
94. Croll, T.I. ISOLDE: a physically realistic environment for model building into low -890
resolution electron-density maps. Acta Crystallogr D Struct Biol 74, 519-530 (2018). 891
95. Liebschner, D. et al. Macromolecular structure determination using X -rays, neutrons 892
and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol 75, 861-893
877 (2019). 894
96. Hall, J. A simple model for determining affinity from irreversible thermal shifts. Protein 895
Sci 28, 1880-1887 (2019). 896
97. Kotov, V. et al. Plasticity of the binding pocket in peptide transporters underpins 897
promiscuous substrate recognition. Cell Rep 42, 112831 (2023). 898
98. Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J Mol Graph 899
14, 33-8, 27-8 (1996). 900
99. Abraham, M.J. et al. GROMACS: High performance molecular simulations through 901
multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19-25 (2015). 902
100. Cannon, W.R., Pettitt, B.M. & McCammon, J.A. Sulfate anion in water: model 903
structural, thermodynamic, and dynamic properties. The Journal of Physical Chemistry 904
98, 6225-6230 (1994). 905
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
27
101. Yoo, J. & Aksimentiev, A. Improved parameterization of amine– carboxylate and 906
amine–phosphate interactions for molecular dynamics simulations using the CHARMM 907
and AMBER force fields. Journal of chemical theory and computation 12, 430-443 908
(2016). 909
102. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. 910
The Journal of chemical physics 126(2007). 911
103. Bernetti, M. & Bussi, G. Pressure control using stochastic cell rescaling. The Journal 912
of Chemical Physics 153(2020). 913
104. Lee, C. et al. Crystal structure of the sodium -proton antiporter NhaA dimer and new 914
mechanistic insights. J Gen Physiol 144, 529-44 (2014). 915
105. Sondergaard, C.R., Olsson, M.H., Rostkowski, M. & Jensen, J.H. Improved Treatment 916
of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa 917
Values. J Chem Theory Comput 7, 2284-95 (2011). 918
106. Kortzak, D. et al. Allosteric gate modulation confers K(+) coupling in glutamate 919
transporters. EMBO J 38, e101468 (2019). 920
107. Kostritskii, A.Y., Alleva, C., Conen, S. & Machtens, J.P. g_elpot: A Tool for Quantifying 921
Biomolecular Electrostatics from Molecular Dynamics Trajectories. J Chem Theory 922
Comput 17, 3157-3167 (2021). 923
108. Kovermann, P., Machtens, J.P., Ewers, D. & Fahlke, C. A conserved aspartate 924
determines pore properties of anion channels associated with excitatory amino acid 925
transporter 4 (EAAT4). J Biol Chem 285, 23676-86 (2010). 926
109. Kovermann, P., Kolobkova, Y., Franzen, A. & Fahlke, C. Mutations associated with 927
epileptic encephalopathy modify EAAT2 anion channel function. Epilepsia 63, 388-401 928
(2022). 929
930
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
The copyright holder for this preprintthis version posted August 19, 2025. ; https://doi.org/10.1101/2025.08.17.670773doi: bioRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.